Brain Tumour Treatment Boosted With Viagra And Levitra
Written by Richard Simmons | Saturday, 05 June 2010 | There are 0 comments
New research shows that it is not only the erectile dysfunction medication Cialis [click here for the Ukmedix News article] that is useful in boosting the effectiveness of brain cancer medications but that both Viagra and Levitra could help in making the chemotherapy medicine Herceptin work better.

Dr. Keith Black who is the Chairman of the department of neurosurgery at Cedars-Sinai as well as the director of the Maxine Dunitz Neurosurgical Institute located in Los Angeles explained that the use of all erectile dysfunction medications could greatly enhance the function of chemotherapeutic agents. He said that it didn’t matter how effective cancer drugs were if they were not able to cross the blood-brain tumour barrier and that it was essential that better ways of getting these drugs to “reach their targets” were researched.
One research project undertaken using lab mice showed that when they were treated with both Levitra and Herceptin the chances of them surviving brain tumours increased by twenty percent when compared to only being given the Herceptin drug.
If it became standard practice for either Viagra, Cialis for Levitra to be added to cancer medications the potential earnings for the drug companies Pfizer, Eli Lilly and Bayer respectively would be huge and thus there is a great deal of interest in this research. Many more years of research will be needed before health authorities around the world approve the use of PDE-5 inhibitors along with cancer medication.
Because of the ability of impotence medication to open blood vessels the range of different applications for them is considerable. Not only do they help millions of men every year to maintain erections [which is in a sense lifesaving!], but they have been used to treat pulmonary arterial hypertension and babies born with heart defects.


